India vs UK Healthcare: A Comparative Analysis of Treatment Speed

This report provides a comparative analysis of the speed of healthcare treatment delivery in the United Kingdom’s National Health Service (NHS) and India’s dual public and private healthcare sectors. The assessment focuses on key metrics including waiting times for general practitioner (GP) consultations, specialist appointments, diagnostic tests, and elective surgeries, alongside specific common treatments.

The analysis reveals that neither country offers unequivocally “faster” treatment across all circumstances. Treatment speed is highly contingent on the type of care required (emergency versus elective), the sector accessed (particularly the public versus private distinction in India), the patient’s financial capacity (a critical factor in India), and geographical location (especially pertinent in India).

The UK’s NHS provides universal access to comprehensive care, largely free at the point of use. However, it faces significant and persistent system-wide waiting times for non-urgent services, including diagnostics, elective surgeries, and some specialist consultations. Official performance targets, such as the 18-week Referral-to-Treatment (RTT) standard, are consistently missed. While emergency care aims for rapid response, it also experiences considerable pressure. Within the NHS, access is primarily rationed by waiting time and clinical priority.

India’s private healthcare sector generally offers substantially faster access to scheduled consultations, diagnostic tests, and elective procedures. Waiting times for planned treatments can be minimal or non-existent for patients who can afford the high out-of-pocket costs or possess comprehensive private health insurance. In this sector, speed is effectively rationed by price.

Conversely, India’s public healthcare sector operates under severe constraints related to funding, staffing, and infrastructure, with disparities particularly pronounced between urban and rural areas. While isolated studies might report short in-clinic waiting times for specific outpatient services, the overall time to access effective treatment is often significantly prolonged due to factors such as long travel distances, difficulties navigating the system, and resource limitations. Standardized national data on waiting times within the public sector is fragmented and lacks the comprehensiveness seen in NHS reporting.

The comparison highlights fundamental trade-offs: the UK system prioritizes equity of access, resulting in longer waiting times for non-urgent care within a universal framework. India’s system offers speed and potentially advanced technology within the private sector, but this is accessible only to the affluent minority, creating a stark two-tier system where the majority face significant barriers to timely care, especially in the public sector and rural regions.

Defining ‘Faster Treatment’: Key Healthcare Waiting Time Metrics

Comparing the “speed” of healthcare systems requires a clear understanding of how waiting times are measured. International bodies and national systems employ various metrics, focusing on different stages of the patient pathway.

International Standards (OECD)

The Organisation for Economic Co-operation and Development (OECD) primarily focuses on waiting times for selected elective (non-emergency) surgeries as a key indicator of health system performance.[1, 2, 3] The main metrics track the time elapsed from the specialist assessment (when a patient is added to the waiting list for a procedure) to the date of treatment.[4] Common measures include:

• Mean and median waiting time in days for patients treated.
• Mean and median waiting time in days for patients still on the list at a census date.
• The percentage of patients waiting longer than a specific threshold, often three months.[4]

Crucially, the standard OECD definition typically excludes the waiting time from the initial referral (e.g., by a GP) to the specialist assessment, sometimes referred to as ‘outpatient waiting time’.[4] This focus allows for more direct comparison of the surgical scheduling phase across countries but does not capture the patient’s entire journey from initial concern or referral. Waiting times are acknowledged as a significant policy concern, reflecting system responsiveness and impacting patient experience.[1, 2, 3]

UK NHS Metrics

The UK’s NHS utilizes a broader and more comprehensive set of metrics, reflecting its constitutional obligations regarding maximum waiting times [5, 6] and its integrated structure. Key metrics include:

• Referral-to-Treatment (RTT): This is a cornerstone metric for non-urgent, consultant-led care in England. It measures the entire patient pathway from the date the referral is received (usually from a GP) to the start of treatment.[5, 7, 8] The operational standard requires that 92% of patients on the waiting list should have waited no longer than 18 weeks.[9, 10, 11] Data collection tracks incomplete pathways (patients still waiting) and completed pathways (patients starting treatment).[8, 12] This metric provides a more holistic view of the elective pathway duration than the typical OECD measure. Performance against this standard has been tracked since 2007.[8, 12] Scotland and Wales have different RTT targets and measurement nuances.[11, 13, 14]
• Diagnostic Waits: A specific target exists for patients waiting for key diagnostic tests (e.g., MRI, CT scans, endoscopies). The NHS Constitution pledge is for waits of less than 6 weeks.[15] Performance is monitored against this, with an operational standard aiming for fewer than 1% of patients waiting longer than 6 weeks.[16] Data is collected monthly for 15 key tests.[16, 17, 18] Scotland also monitors waits for 8 key diagnostic tests.[13, 19]
• Cancer Waits: The NHS has specific, time-sensitive targets for cancer pathways, which were streamlined in England from October 2023.[20, 21, 22] The main standards are:

• Faster Diagnosis Standard (FDS): Maximum 28 days from urgent referral (GP or screening) to the point the patient is told they have cancer or cancer is definitively excluded. The target is 75%, with an ambition to reach 80%.[5, 20, 21, 22, 23, 24, 25]
• 31-day Standard: Maximum 31 days from the decision to treat to the first definitive treatment for all cancer patients. The target is 96%.[20, 21, 22, 24, 25, 26]
• 62-day Standard: Maximum 62 days from an urgent referral (GP, screening, or consultant upgrade) to the start of the first definitive treatment. The target is 85%.[20, 21, 22, 23, 24, 25, 26, 27]

• GP Appointment Access: While there isn’t a single national waiting time target for GP appointments, access remains a major policy focus and a primary driver of public satisfaction/dissatisfaction.[28, 29, 30, 31] NHS Digital collects data on the time elapsed between booking and the appointment date.[30] Patient surveys also gauge the ease and timeliness of securing appointments.[28, 32, 33]
• Mental Health (NHS Talking Therapies): Specific targets exist for accessing psychological therapies for anxiety and depression. For referrals finishing treatment, the aim is for 75% to access services within 6 weeks of referral and 95% within 18 weeks.[34, 35, 36]
• Accident & Emergency (A&E) Waits: A long-standing operational standard requires 95% of patients attending A&E to be admitted, transferred, or discharged within 4 hours of arrival.[6, 23, 27, 37]

The breadth of these metrics reflects the NHS’s commitment to monitoring performance across diverse service lines within its publicly funded framework. The RTT standard, in particular, offers a comprehensive view of the elective care journey duration.

Indian Healthcare Metrics

In contrast to the NHS, India lacks a standardized, nationally reported system for tracking healthcare waiting times across different stages of care, for both public and private sectors. Consequently, assessing treatment speed relies on a combination of:

• Academic Studies: Research often measures waiting times within specific contexts, such as:

• Outpatient Clinic Wait Time: Time from arrival at the clinic/hospital to consultation with a doctor.[38, 39, 40]
• Emergency Department (ED) Wait Time: Time from arrival to being attended by medical staff, or time until disposition (admission/discharge).[41, 42]
• Time-to-Treatment Initiation (TTI): Primarily studied for cancer, measuring the duration between diagnosis and the start of the first treatment.[43, 44]

• Private Sector Marketing: Private hospitals and medical tourism facilitators frequently advertise minimal or “zero” waiting times for procedures as a key selling point.[45, 46, 47, 48, 49]
• Government Initiatives: Some government efforts focus on specific bottlenecks, like the “Scan and Share” QR-code based Outpatient Department (OPD) registration system designed to reduce queues at registration counters.[50]

The absence of consistent, publicly available, system-wide waiting time data like the NHS RTT makes direct and comprehensive comparisons challenging. This data gap itself reflects the fragmented nature of India’s healthcare system, with its mix of public and private providers operating under varying state-level regulations and lacking a unified constitutional mandate for specific waiting time guarantees. Analysis must therefore piece together information from disparate sources and acknowledge significant limitations in data availability and comparability.

Defining “Faster” for this Report

For the purpose of this comparison, “faster treatment” will be assessed across multiple dimensions, considering the available data: time to access primary care (GP), time from referral to specialist consultation (where measurable), time taken for diagnostic tests, time from the decision-to-treat to the actual procedure (particularly for elective surgery and cancer), and, where applicable (primarily NHS), the overall RTT duration.

Waiting Times in the UK’s National Health Service (NHS)

Waiting times within the NHS are a major public concern and a key indicator of system pressure.[10, 28] Despite constitutional rights to treatment within maximum times [5, 6], performance against key targets has deteriorated significantly over the past decade, a trend exacerbated but not solely caused by the COVID-19 pandemic.[27, 51]

Referral-to-Treatment (RTT) for Elective Care

The 18-week RTT standard (92% of patients waiting less than 18 weeks from referral to treatment) is the benchmark for non-urgent, consultant-led elective care.[9, 10, 11]

• Performance vs. Target: This standard has not been met nationally in England since September 2015.[6, 10, 27] Performance has fallen dramatically; for instance, in February 2025, only 59.2% of patients on the list had been waiting less than 18 weeks.[23] Figures from late 2024 cited performance at just 59%.[9]
• Waiting List Size: The elective care waiting list has grown substantially, reaching record levels post-pandemic before showing recent slight decreases. In February 2025, the list stood at 7.40 million cases, corresponding to 6.24 million unique patients (as some individuals wait for multiple treatments).[23] This compares to around 4.4 million pathways pre-pandemic (February 2020).[52]
• Waiting Duration: The median waiting time for patients still waiting to start treatment was 14.2 weeks in February 2025, more than double the median wait of 6.7 weeks in February 2020.[23] Analysis from late 2023 also placed the median wait at 14 weeks.[52]
• Long Waits (>52 weeks): NHS England aims to eliminate waits exceeding 52 weeks.[10] However, the number of patients waiting this long surged during the pandemic, peaking at around 436,000 in March 2021.[10] While numbers have reduced, they remain exceptionally high compared to pre-pandemic levels (under 5,000 before COVID-19 [10]). In March 2024, around 309,000 people were waiting over 52 weeks [10], and in February 2025, the figure was approximately 194,000.[37] The target is to eliminate these waits by March 2025 [10], later revised to reduce them to less than 1% of the list by March 2026.[37] Waits exceeding 78 weeks and 104 weeks also became significant issues post-pandemic, although substantial progress has been made in reducing the longest waits.[52]
• Specialty Variations: Waiting times and list sizes vary considerably between specialties. Trauma and Orthopaedics (T&O) consistently has the largest waiting list (over 800,000 in March 2024 [10]). Ophthalmology also has a very large list.[10, 53] In March 2024, Ear, Nose and Throat (ENT) had the highest proportion of patients waiting over 18 weeks (51%).[10] No specialty was meeting the 18-week standard as of March 2024.[10] The independent sector plays a significant role in delivering NHS-funded care in high-volume specialties like T&O and Ophthalmology, often with shorter waiting times compared to NHS providers (average 12 weeks vs 19 weeks for completed pathways in Feb 2024).[54]

The persistent failure to meet the RTT standard reflects a deep-seated imbalance between demand and capacity within the NHS, driven by factors including funding pressures, staffing constraints, and rising patient need, which long predated the pandemic.[51] The sheer scale of the current backlog means that returning to the 18-week standard is a multi-year challenge requiring sustained increases in activity.[9, 51]

Diagnostic Test Waits

Timely diagnostic tests are crucial for enabling subsequent treatment decisions.[17]

• Performance vs. Target: The standard that fewer than 1% of patients should wait more than 6 weeks for one of the 15 key diagnostic tests has not been met nationally since February 2017.[15, 55] Performance deteriorated sharply during the pandemic, with 58% waiting over 6 weeks in May 2020.[15] While activity levels have recovered and now exceed pre-pandemic levels [15], performance remains poor. In January 2024, 26% (414,353 people) were waiting over 6 weeks [15], and in February 2025, this figure was 17.5%.[23] The total diagnostic waiting list stood at around 1.6 million in November 2024.[55] The median wait for a diagnostic test was 2.6 weeks in February 2025.[23]
• Variations: Waits vary by test type. In January 2024, tests like audiology assessments, echocardiography, gastroscopy, and colonoscopy had a higher proportion (31-41%) waiting over 6 weeks compared to more common tests like CT scans (16%) and non-obstetric ultrasounds (21.3%).[15] In Scotland, as of December 2024, endoscopy tests accounted for 98% of waits over 52 weeks for the 8 key tests monitored there.[19]

Diagnostic delays create significant bottlenecks in patient pathways, contributing to longer waits for treatment, including RTT and cancer care.[17, 51] Contributing factors include limitations in equipment capacity (the UK has fewer CT and MRI scanners per capita than many comparable countries [55]) and shortages of specialist staff.[55]

Cancer Waiting Times

Meeting cancer waiting time standards is critical for improving patient outcomes and reducing anxiety.[20, 24, 25]

• Performance vs. Targets (Post-Oct 2023 Standards):

• Faster Diagnosis Standard (28 days): Performance against the 75% target has been variable but showed improvement in late 2024/early 2025. It was met in November 2024 (77%) [24], December 2024 (78.1%) [20], and February 2025 (80.2%, exceeding the target).[23] This suggests progress in speeding up the diagnostic phase for suspected cancer.
• 31-day Decision-to-Treat to Treatment: The 96% target remains challenging. Performance was 91% in November 2024 [24] and 91.5% in December 2024.[20]
• 62-day Referral to Treatment: The 85% target continues to be severely missed, a trend ongoing since 2015.[20, 24] Performance was 71.3% in December 2024 (on the new, broader definition) [20, 27] and 67% in February 2025.[23] Under the previous definition, performance had fallen to as low as 59% in Q4 2022/23.[24]

These figures indicate that while the initial diagnostic part of the pathway (FDS) may be improving, significant delays persist in starting treatment once cancer is diagnosed or a treatment decision is made. Delays at this stage can negatively impact survival rates.[20] The persistent failure to meet the 62-day standard highlights ongoing pressures in diagnostics and treatment capacity (surgery, radiotherapy, chemotherapy).[24] The focus on targets is known to influence hospital behaviour, particularly for standards with financial implications or high visibility, like the 62-day standard.[26]

GP Appointment Access

The ease and speed of accessing GP appointments are major determinants of public satisfaction with the NHS.[30, 31]

• Performance/Patient Experience: There is widespread public dissatisfaction with GP access, with 62% reporting dissatisfaction with the time it takes to get an appointment in a 2024 survey.[28, 29] Improving GP access is consistently ranked as a top priority by the public.[28, 29, 31]
• Appointment Timeliness: NHS Digital data shows a high proportion of appointments occur quickly: in May 2023, 43.9% took place on the same day they were booked, and 51.5% occurred within 48 hours (same or next day).[30] This aligns with patient-reported data from the 2023 GP Patient Survey.[30]
• Booking Challenges: Despite rapid access for many, challenges remain. In May 2023, 12.7% of appointments took place 15-28 days after booking.[30] Furthermore, 28% of patients reported a poor experience of booking an appointment. Key reasons cited for not getting an appointment included inability to book ahead (24.9%) or not getting an appointment at the desired day/time (31.8%), rather than the appointment offered not being soon enough (11.2%).[30]

This suggests a complex picture where, although many urgent needs are met quickly, difficulties with the booking process itself, securing routine appointments, and booking appointments in advance contribute significantly to patient frustration and the perception of poor access.[30] Delays at this initial stage can also have knock-on effects, potentially delaying necessary referrals into secondary care pathways.

Accident & Emergency (A&E) Waits

A&E performance is a highly visible indicator of urgent care pressures.

• Performance vs. Target: The 4-hour standard (95% seen/treated/admitted/discharged within 4 hours) has been consistently missed for years.[27] Performance worsened significantly after the pandemic, reaching a low point in December 2022 (50.4% waiting over 4 hours).[27] Recent figures show some improvement but remain far from the target; 75.0% were seen within 4 hours in January 2025 [37], compared to 73.3% the previous month. Public satisfaction with A&E is at a record low (19% satisfied, 52% dissatisfied in 2024).[28]
• Long Waits: Waits exceeding 12 hours from the decision to admit to actual admission (trolley waits) increased dramatically post-pandemic.[27] In March 2025, over 46,000 patients waited more than 12 hours for a hospital bed after a decision to admit.[23]

A&E waiting times are strongly influenced by factors beyond the department itself, particularly issues with patient flow throughout the hospital and delays in discharging medically fit patients, often linked to social care capacity.[51, 56] These prolonged waits signify severe strain across the entire urgent and emergency care system.

Waiting Times in India’s Healthcare System

Assessing waiting times in India presents a different set of challenges compared to the UK, primarily due to the dual nature of the system (public and private) and the lack of comprehensive, standardized national data collection.

1.Public Sector Landscape

India’s public healthcare system, intended to provide affordable care, particularly to the large rural population and the poor, faces substantial challenges that impact waiting times and overall access.

• Data Limitations: Unlike the NHS, there are no routinely published national statistics for metrics like RTT or standardized diagnostic/cancer waits in the public sector. Understanding waiting times relies heavily on localized academic studies, anecdotal reports, and proxy indicators.
• Outpatient and Emergency Waits: Studies reveal a mixed picture, likely varying significantly by location and facility type. A 2012 study in Nellore district found an average outpatient wait (arrival to consultation) of 20.3 minutes in government hospitals.[38, 39] However, this contrasts sharply with a study in two Western India tertiary care hospitals where the average wait from hospital entry to being attended in the emergency department was 2.1 hours.[41] Reviews suggest typical developing country waits can be 2-4 hours.[40] Emergency departments in tertiary centres are often reported as overcrowded, leading to long waits for assessment, diagnostics (median 1 hour wait in one study), observation (median 16 hours), and procedures (median 38 hours wait for surgery post-decision).[41, 42] Factors contributing to ED delays include inefficient patient flow, staff shortages, and bottlenecks both within the ED and in accessing inpatient beds or tests elsewhere in the hospital.[42]
• Infrastructure and Staffing Constraints: The public sector is severely under-resourced. India has a very low density of hospital beds overall (~0.5 per 1000 people [57]), and public facilities, especially in rural areas, suffer from inadequate infrastructure.[58, 59, 60, 61] There’s a critical shortage of qualified healthcare professionals, with doctor density at ~0.9 per 1000 [62, 63] and nurse density at ~1.7 per 1000 [64, 65] – well below WHO recommendations.[64] Compounding the shortage is a severe maldistribution: an estimated 80% of specialists work in urban areas, while 70% of the population lives rurally.[61] Rural public facilities often rely on inexperienced or unmotivated staff [66], and face significant shortfalls in required facilities like Community Health Centres (CHCs).[59] These constraints directly limit service capacity, inevitably leading to delays and long queues.[41, 42, 60, 66]
• Urban vs. Rural Disparity: The gap between urban and rural healthcare access and quality is immense.[58, 59, 67] Around 75% of India’s health infrastructure serves the 27% of the population living in urban areas.[59, 67] Rural residents often face journeys exceeding 100 km to reach adequate facilities, navigating poor roads and transport.[59, 67] This geographical barrier adds significantly to the effective waiting time for care, far beyond any time spent queuing within a clinic. Rural areas also have lower health indicators and higher reliance on unqualified local providers.[67]
• Perceived Quality and System Navigation: A significant portion of the population perceives the quality of care in the public sector as poor, citing this as a primary reason for opting for private care when possible.[66, 68] Navigating the public system, dealing with registration queues (which initiatives like QR codes aim to shorten [50]), and moving between departments can add further delays.[41]
• Government Initiatives: The National Health Mission (NHM), launched in 2005, aimed to strengthen public health infrastructure and workforce, particularly in rural areas, and has shown some impact in increasing patient loads over time.[69, 70] Schemes like Ayushman Bharat (PM-JAY) aim to provide financial protection for hospitalisation for vulnerable populations.[66]

In summary, while specific in-clinic wait times in India’s public sector might occasionally appear short in limited studies, systemic underfunding [60, 68], chronic shortages of staff and infrastructure [61, 67], geographical barriers (especially rural) [59, 67], and process inefficiencies [41, 42] combine to create substantial delays and access barriers for a large part of the population. The effective waiting time, encompassing travel and system navigation, is likely very long for many, particularly in rural India.

2. Private Sector Landscape

India’s large and growing private healthcare sector operates on different principles, significantly impacting treatment speed for those who can access it.

• Speed as a Market Feature: Private hospitals and clinics often explicitly market speed and efficiency, promising minimal or even “zero” waiting times for consultations and procedures.[45, 46] Examples include Apollo Hospitals highlighting techniques that shorten waits for certain transplants [71] and medical tourism facilitators guaranteeing quick attention.[45] This contrasts sharply with the public sector’s known delays.
• Observed Faster Access: Studies and reports confirm faster access in the private sector for various services. Outpatient waiting times (arrival to consultation) were found to be shorter in private hospitals compared to government ones in one district study (15.5 vs 20.3 minutes).[38, 39] Scheduling for elective surgeries like cataracts is reported to be much faster, often within days or weeks of consultation.[72, 73] Similarly, hip replacement surgery is likely accessed far quicker than in the public sector or NHS.[48, 49] For cancer care, having private insurance (often used for private facilities) is associated with more timely treatment initiation.[43, 44, 74]
• Cost as the Primary Barrier: The speed and perceived higher quality [75] of the private sector come at a significant cost. India has one of the highest rates of out-of-pocket expenditure (OOPE) on healthcare globally, estimated at around 50% of total health expenditure [76, 77, 78], compared to ~13.5% in the UK [77, 79] and a global average of ~17%.[80] This reliance on OOPE makes private healthcare unaffordable for a vast proportion of the population.[68, 80] OOPE is demonstrably higher for care sought in private facilities compared to public ones.[75, 76] Healthcare costs frequently lead to catastrophic health expenditure for households, forcing them to borrow money or sell assets, and pushing millions into poverty each year.[66, 68, 76, 80] Medical inflation further exacerbates this issue.[81]
• Role and Limitations of Health Insurance: Health insurance coverage in India remains relatively low. While growing, estimates suggest around 30% of the population (40 crore individuals) lack any financial protection for health [80], with penetration around 37-38% cited in other sources.[82] There is a “missing middle” – populations not poor enough for government schemes but unable to afford private insurance.[80] Government schemes like Rashtriya Swasthya Bima Yojana (RSBY) and the current Pradhan Mantri Jan Arogya Yojana (PM-JAY) under Ayushman Bharat aim to cover vulnerable populations, primarily for hospitalisation.[66, 83] Where available and utilized, insurance significantly improves access, reduces OOPE [75, 84], and can expedite treatment initiation, as seen in cancer care.[43, 44] However, even among those eligible or enrolled, utilization can be hampered by lack of awareness, complex procedures, or inability to use the insurance effectively.[83] Cashless treatment options, where insurers pay providers directly, aim to simplify processes and reduce upfront financial burden, thereby speeding up access.[82] Corporate health plans also exist but may have coverage limitations.[81]

The Indian private sector offers a pathway to rapid healthcare access, driven by market competition and catering to paying customers and medical tourists.[38, 45] However, this speed is largely inaccessible to the majority due to prohibitive costs. This creates a deeply inequitable system where socioeconomic status is the primary determinant of how quickly one receives non-emergency care. Health insurance provides a crucial bridge for some, but its limited reach and utilization challenges mean that OOPE remains the dominant financing mechanism, effectively rationing timely care based on wealth.

Comparative Waiting Times for Common Treatments

Directly comparing waiting times for specific procedures provides a tangible illustration of the differences between the UK NHS and India’s public and private sectors.

Cataract Surgery

• UK NHS: Patients face substantial waits, routinely exceeding the 18-week RTT target.[10] Ophthalmology has large waiting lists.[10] Median waits are not explicitly stated in recent overall RTT data but are likely several months. Specific hospital trust data cited from 2024 indicated average waits of 39 weeks (Chesterfield) and 45 weeks (Dorset) for ophthalmology treatment.[47] Older data mentioned waits up to 94 weeks at one hospital, though the shortest was 10 weeks.[47] A significant volume of NHS cataract surgery is performed by the independent sector, potentially offering faster treatment for NHS patients referred there.[54]
• India Private: Access is significantly faster. Private hospitals and clinics often schedule surgery within days or a few weeks of the initial consultation.[72] This speed, combined with access to advanced technologies (e.g., laser-assisted surgery) and premium intraocular lenses (IOLs), makes it an attractive option for those who can afford it.[72] UK private providers (used as a benchmark) advertise waits of 4-6 weeks.[47]
• India Public: Precise data is scarce, but long waiting lists are highly likely due to the high volume of cataract procedures performed annually (over 6.5 million [72]), limited specialist availability, and resource constraints, particularly in rural areas.[72] Government schemes offer free or heavily subsidized surgery, usually with standard monofocal IOLs, but accessing these may involve delays related to eligibility verification and scheduling backlogs.[72]
• Comparison: For cataract surgery, India’s private sector offers the fastest route to treatment by a significant margin, provided the patient can pay. The UK NHS involves lengthy waits, often many months, well beyond target times. India’s public sector likely also involves long waits, potentially comparable to or longer than the NHS, compounded by access barriers, although standardized data is lacking.

Hip Replacement

• UK NHS: Waiting times are notoriously long. Trauma & Orthopaedics (T&O), which covers hip replacements, consistently has the largest RTT waiting list in England.[10] The 18-week target is routinely missed for this specialty.[10] Median waits are likely many months. The pandemic significantly worsened waits for T&O.[48, 53] As with cataracts, the independent sector performs a substantial number of NHS hip replacements, potentially reducing waits for those patients.[54]
• India Private: Offers potentially much faster surgery. Medical tourism sites claim “almost zero wait list” for hip replacement in top Indian private hospitals.[49] UK private providers advertise waits of 4-6 weeks from enquiry to surgery [48], suggesting Indian private facilities offer similar or even faster timelines for self-paying patients.
• India Public: Specific waiting time data for hip replacement in the Indian public sector is not available in the provided materials. However, given the general constraints on staffing, infrastructure, and funding, waits are expected to be extremely long, likely exceeding those in the NHS. Prioritization based on clinical need versus ability to pay might also differ compared to private settings.[85]
• Comparison: Similar to cataracts, India’s private sector provides the quickest option for hip replacement for paying patients. NHS waiting times are substantial. India’s public sector likely involves the longest waits, though data is insufficient for precise quantification.

Cancer Treatment Initiation

Comparing cancer treatment speed is more complex due to different metrics and pathway variations.

• UK NHS: The key target is the 62-day standard (urgent referral to first treatment), aiming for 85% compliance.[20, 24] This target has been consistently missed since 2015 [20, 24], with recent performance often below 70% (e.g., 67% Feb 2025, 71.3% Dec 2024).[20, 23, 27] This means over 30% of urgently referred patients wait longer than two months to start treatment. The 31-day decision-to-treat to treatment standard (96% target) is also missed (around 91-91.5% recently).[20, 24] These figures point to significant delays occurring after the initial referral or decision to treat.
• India (Mixed Data): A large study based at a major Indian cancer centre (likely treating a mix of public, insured, and private patients) reported a median Time-to-Treatment Initiation (TTI) from diagnosis of 20 days.[43, 44] This appears faster than the typical NHS experience based on the 62-day performance. However, the mean TTI in the same study was much longer at 53.7 days, indicating a skewed distribution with some very long waits.[43, 44] Furthermore, TTI varied significantly by cancer type (median 29 days for Head & Neck) and treatment modality (median 27.5 days for radiotherapy).[43, 44] Another study focusing solely on Head & Neck cancer patients (often presenting to public centres after initial private contact) found a median treatment interval (diagnosis to initiation) of 65.5 days.[86]
• India (Role of Sector/Insurance): The positive impact of government insurance (PM-JAY) on achieving timely TTI (within 30 days) was significant, suggesting financial barriers are a major cause of delay.[43, 44] Patients often initiate contact in the private sector but may face delays if subsequently treated in overburdened public centres.[86] International evidence also links private insurance to shorter cancer treatment times.[74]
• Comparison: This comparison is nuanced. The median TTI reported in one major Indian study (20 days) suggests potentially faster initiation than the NHS 62-day pathway performance for many patients. However, the longer mean TTI and specific examples (Head & Neck cancer, radiotherapy) indicate substantial delays exist in India too. Critically, access to this faster median time in India appears heavily influenced by socioeconomic factors (insurance coverage, ability to pay for private care).[43, 44] The NHS, while struggling with systemic delays impacting a large proportion of patients, provides access within a universal framework, meaning delays are primarily system-related rather than based on ability to pay. Therefore, an insured or affluent patient in India might start cancer treatment faster than the average NHS patient, but an uninsured or poor patient in India could face delays comparable to or exceeding those in the NHS, compounded by access barriers.

Table 1: Comparative Waiting Times for Selected Treatments (Illustrative Estimates)

Metric / Procedure	UK NHS (England)	India – Private Sector	India – Public Sector	Summary for Speed
RTT Pathway (Referral to Treatment)	Benchmark: 18 weeks (target). Performance: < 60% within 18 weeks. Median wait: ~14 weeks (patients still waiting). List size: 7.4M cases / 6.2M patients (Feb 2025). Long waits (>52w): ~194,000 (Feb 2025). [9, 10, 23, 52]	Not a standard metric. Rapid access for consultations and procedures is a key selling point, suggesting very short overall pathway times. [45, 46, 49]	No standardized data. Likely very long due to resource constraints, geographical barriers, and system navigation difficulties, especially for complex/elective care. [41, 42, 59, 60, 67]	Private India > NHS > Public India (likely)
Cataract Surgery	Waits: Significantly exceed 18 weeks. Ophthalmology has large lists. Median waits likely several months. Examples: 39-45 weeks average at some trusts. [10, 47]	Waits: Very fast, often within days or a few weeks of consultation. [72]	No specific data, but likely long waits due to high volume, limited specialists, and resource constraints. Potentially comparable to or longer than NHS. [72]	Private India >>> NHS >= Public India (likely)
Hip Replacement	Waits: Very long. T&O has the largest waiting list. Significantly exceeds 18 weeks. Median waits likely many months. [10, 48]	Waits: Very fast, potentially “zero waitlist”. Likely days/weeks. [49]	No specific data, but likely extremely long waits due to complexity, cost, and resource scarcity. Likely much longer than NHS. [85]	Private India >>> NHS >> Public India (likely)
Cancer Treatment Initiation (Urgent Referral / Diagnosis to First Treatment)	NHS: 62-day standard (85% target) consistently missed, often < 70% compliance. Significant delays (>2 months) for >30% of patients. 31-day Decision-to-Treat also missed (target 96%, performance ~91%). [20, 23, 24, 27]	India (Mixed): Median TTI (Diagnosis to Tx) ~20 days in one major study. Faster than NHS median, but skewed data (mean 54 days). [43, 44]	India (Mixed): Slower TTI likely for uninsured/poor, particularly in public sector. Median TTI 65.5 days for Head & Neck in one study (often treated publicly). Access influenced by insurance/affluence. [43, 44, 86]	Private India (or insured patient) likely faster median time than NHS average. NHS provides universal (though delayed) access. Uninsured/poor in India likely face longest delays. Outcome depends heavily on patient circumstances in India.
GP / Primary Care Access	UK NHS: High patient dissatisfaction with access (62% in 2024). Booking challenges are common. However, ~44% same-day, ~52% within 48hrs. [28, 29, 30]	India Private: Often walk-in or easy appointment booking. Shorter clinic waits (e.g., ~15 mins) than public (e.g., ~20 mins) in one study. [38, 39]	India Public: Highly variable. Short in-clinic waits (~20 mins) in some studies [38, 39], but long ED waits (hours) [41] and potential delays from travel/queues. [50, 59, 67]	Private India often offers faster, more convenient scheduled or walk-in access. NHS offers rapid access for many booked urgent needs but faces booking hurdles. Public India access speed is highly variable and often hampered by systemic issues and geography. Nuanced comparison depending on context.
Diagnostic Tests (e.g., MRI/CT)	UK NHS: 6-week wait target (<1% waiting longer) missed since Feb 2017. Recent performance ~17.5% waiting >6 weeks (Feb 2025). Median wait 2.6 weeks. [15, 23, 55]	India Private: Generally rapid access, often same-day or within a few days for common scans, especially for self-paying patients.	India Public: Likely long delays due to equipment scarcity, particularly in rural areas, and high demand. No standardized data.	Private India > NHS > Public India (likely)
Emergency Care (A&E / ED)	UK NHS: 4-hour target (95%) consistently missed. Performance ~75% (Jan 2025). Significant waits >4 hours and >12 hours (trolley waits) common. [23, 27, 37]	India Private: Likely faster initial assessment if affordable, but potentially high costs.	India Public: Variable. Can be very crowded with long waits for assessment (e.g., >2 hours), diagnostics, and procedures (e.g., median 38 hours for surgery). [41, 42]	Private India likely fastest initial access (if affordable). NHS faces significant delays beyond 4 hours. Public India EDs often severely overcrowded with long waits for subsequent steps. Again, nuanced; initial assessment vs. overall time to definitive care.

Note: Estimates for India’s public sector are often inferred due to data scarcity. NHS data primarily refers to England unless specified. TTI = Time-to-Treatment Initiation.

Factors Influencing Waiting Times

Several underlying factors contribute to the waiting times observed in both the UK and Indian healthcare systems.

UK NHS:

• Demand vs. Capacity: The core issue is a persistent mismatch between rising demand for healthcare services (driven by an ageing population, increasing prevalence of chronic conditions, and advances in treatment) and the available capacity (funding, staffing, infrastructure).[9, 51] The NHS operates close to maximum capacity much of the time.
• Funding: While NHS funding has increased over time, periods of slower growth (especially 2010-2019) relative to demand have contributed to performance deterioration.[51] The level of funding directly impacts staffing levels, equipment availability, and the ability to expand services.
• Staffing: Shortages of key staff groups, including doctors (GPs, specialists), nurses, and diagnostic technicians, are a critical constraint.[51, 55] Brexit has also impacted recruitment and retention in some areas.[51] Staff burnout and morale issues further affect productivity and retention.
• Infrastructure: Limitations in physical infrastructure, such as the number of hospital beds, operating theatres, and diagnostic scanners (particularly MRI/CT compared to international averages [55]), restrict throughput.
• Social Care Interface: Delays in discharging medically fit patients from hospital (‘delayed discharges’ or ‘bed blocking’) significantly impact hospital capacity, contributing to A&E waits and cancellation of elective surgeries.[51, 56] This is often linked to insufficient capacity or funding within the social care system.
• COVID-19 Pandemic Impact: The pandemic severely disrupted services, creating a huge backlog of unmet need and exacerbating existing pressures.[9, 51, 52] While activity has recovered, dealing with the backlog adds immense strain.
• Efficiency and Productivity: While the NHS is considered relatively efficient internationally in terms of administrative costs, there are ongoing efforts to improve productivity and streamline patient pathways (e.g., through integrated care systems, diagnostic hubs).[51]

India:

• Funding: Public health expenditure in India remains low as a percentage of GDP (around 1.2-1.3% [60, 68, 76]) compared to the UK (~8-10% directed to NHS [79]) and other developed nations. This chronic underfunding is the root cause of many public sector deficiencies.[60, 68]
• Staffing (Public Sector): Severe shortages and maldistribution of doctors, nurses, and specialists plague the public system, especially in rural areas.[61, 64, 67] This limits service availability and increases waits.
• Infrastructure (Public Sector): Inadequate numbers of hospitals, beds, diagnostic equipment, and basic facilities, particularly outside major urban centres, create significant bottlenecks.[58, 59, 67]
• Rural-Urban Divide: Vast disparities in infrastructure, staffing, and accessibility between urban and rural areas mean geography is a major determinant of waiting times and access quality.[58, 59, 67]
• Regulation and Quality Control: Regulation of the private sector is fragmented, leading to variations in quality and cost.[66] While the public sector has standards, enforcement can be weak.
• Out-of-Pocket Expenditure (OOPE): The high reliance on OOPE acts as a major financial barrier, delaying or preventing access to care (especially timely private care) for the majority of the population.[68, 76, 80]
• Health Insurance Penetration: Limited insurance coverage means financial constraints dictate access speed for many, particularly in the private sector.[80, 82] Even with insurance, navigating claims can sometimes cause delays.
• Dominance of Private Sector: The growth of the private sector, while offering options for some, has potentially drawn resources (staff) away from the public sector and contributes to the two-tier system.[66]

Conclusion: Which Country Offers Faster Treatment?

There is no single answer to whether the UK or India offers “faster” healthcare treatment. The reality is highly dependent on the specific circumstances:

1. For Emergency Care: Both systems aim for rapid response, but both face significant pressures. UK A&E departments experience long waits beyond the initial assessment due to system-wide blockages.[27, 37] Indian public EDs can be severely overcrowded with long waits for diagnostics and interventions.[41, 42] Access speed in India’s private EDs depends on affordability. It’s unclear which system guarantees faster definitive emergency treatment consistently.
2. For Elective Procedures (e.g., Cataracts, Hip Replacement):

• India’s Private Sector is significantly faster than the UK NHS. For patients who can afford to pay out-of-pocket or have comprehensive private insurance, waiting times for consultations, diagnostics, and surgery can be minimal (days or weeks).[49, 72]
• The UK NHS involves substantial waits, often many months, routinely exceeding the 18-week target.[10, 47, 48] Access is rationed by time and clinical priority within a universal system.
• India’s Public Sector likely involves very long waits, potentially exceeding NHS waits, due to severe resource constraints, although concrete comparative data is scarce.[59, 60, 67]

3. For Cancer Treatment: The comparison is nuanced. An insured or affluent patient in India might experience faster median time from diagnosis to treatment initiation compared to the average NHS patient facing delays against the 62-day target.[20, 24, 43, 44] However, the NHS provides a universal pathway (albeit delayed for many), whereas access speed in India is heavily influenced by socioeconomic status, with potentially very long waits for the poor or uninsured.[43, 44, 86]
4. For Primary Care/GP Access: Private clinics in India often offer faster walk-in or scheduled appointment access than navigating the booking system for a routine NHS GP appointment.[30, 38, 39] However, the NHS does provide same-day/next-day access for a large proportion of urgent booked appointments.[30] Access speed in India’s public primary care is variable and often hampered by travel and queues.[38, 39, 50, 59]
5. For Diagnostic Tests: India’s private sector generally offers much faster access (often same-day/next-day) than the NHS, where waits frequently exceed the 6-week target.[15, 23, 55] India’s public sector likely faces significant delays due to equipment scarcity.

In essence:

• If speed is the absolute priority and cost is not a barrier, India’s private healthcare sector offers faster treatment, particularly for elective procedures and diagnostics.
• If guaranteed access regardless of ability to pay is the priority, the UK NHS provides this, but patients must accept potentially long waiting times for non-urgent care. The speed disadvantage is a consequence of its universal, publicly funded model operating under significant strain.
• For the majority of India’s population reliant on the public sector or facing high out-of-pocket costs, access to timely treatment is likely slower and more challenging than in the UK NHS, particularly when factoring in geographical barriers and system navigation difficulties in addition to potential in-clinic waits.

The choice between the systems reflects a fundamental difference in philosophy: the NHS prioritizes universality and equity (rationed by time), while India’s system offers speed for the affluent (rationed by price) alongside a struggling public sector providing basic access for the masses. Neither system currently provides rapid, high-quality, accessible care for all its citizens across all types of need.

References

[1] OECD. Waiting times for health services: Next in line. OECD Health Policy Studies. 2020. Available from: https://www.oecd.org/health/health-systems/Waiting-times-for-health-services-Next-in-Line-OECD-Health-Policy-Studies-2020.pdf

[2] OECD. Health at a Glance 2023: OECD Indicators. 2023. Available from: https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2023_19991312

[3] Siciliani L, Moran V, Borowitz M. Measuring and comparing health care waiting times in OECD countries. OECD Health Working Papers No. 67. 2013. Available from: https://www.oecd-ilibrary.org/social-issues-migration-health/measuring-and-comparing-health-care-waiting-times-in-oecd-countries_5k4ddxwrqk5h-en

[4] Adan L, Furst M, Lorenzoni L. Health system responses to the COVID-19 pandemic: OECD assessment of country approaches to strengthen health system resilience. OECD Health Working Papers No. 159. 2023. Available from: https://www.oecd-ilibrary.org/social-issues-migration-health/health-system-responses-to-the-covid-19-pandemic_e5d4778c-en

[5] GOV.UK. The NHS Constitution for England. Updated 15 May 2024. Available from: https://www.gov.uk/government/publications/the-nhs-constitution-for-england/the-nhs-constitution-for-england

[6] House of Commons Library. NHS maximum waiting time standards. Research Briefing CBP07281. 24 January 2024. Available from: https://researchbriefings.files.parliament.uk/documents/CBP-7281/CBP-7281.pdf

[7] NHS England. Referral to treatment (RTT) waiting times. Available from: https://www.england.nhs.uk/statistics/statistical-work-areas/rtt-waiting-times/

[8] NHS England. Referral to Treatment Waiting Times Statistics: Statistical Note for Users. April 2021. Available from: https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2021/04/Statistical-Note-RTT-April-2021-PDF-176K-09836.pdf

[9] The King’s Fund. NHS waiting lists. 13 February 2024. Available from: https://www.kingsfund.org.uk/insight-and-analysis/press-releases/nhs-waiting-lists

[10] The Health Foundation. Waiting lists. Updated 23 April 2024. Available from: https://navigator.health.org.uk/theme/waiting-lists

[11] British Medical Association (BMA). Waiting list pressures. Updated 10 April 2024. Available from: https://www.bma.org.uk/advice-and-support/nhs-delivery-and-workforce/pressures/nhs-waiting-lists-tracker

[12] NHS England. Guide to consultant-led Referral to Treatment (RTT) Waiting Times Rules. Version 2. 2015. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/485189/RTT_rules_suite_guide_V2.pdf

[13] Public Health Scotland. Waiting Times: Elective care. Available from: https://www.publichealthscotland.scot/our-areas-of-work/healthcare-assessment-and-scientific-advice/scottish-health-and-social-care-data/waiting-times/elective-care/

[14] StatsWales. Referral to treatment waiting times. Available from: https://statswales.gov.wales/Catalogue/Health-and-Social-Care/NHS-Waiting-Times/Referral-to-Treatment

[15] The Health Foundation. Diagnostic test waiting times. Updated 23 April 2024. Available from: https://navigator.health.org.uk/theme/diagnostic-test-waiting-times

[16] NHS England. Diagnostic Waiting Times and Activity. Available from: https://www.england.nhs.uk/statistics/statistical-work-areas/diagnostics-waiting-times-and-activity/

[17] The King’s Fund. Diagnostic test waiting times. Updated 11 April 2024. Available from: https://www.kingsfund.org.uk/insight-and-analysis/data-and-charts/diagnostic-test-waiting-times

[18] NHS England. Monthly Diagnostics Data 2024-25. Available from: https://www.england.nhs.uk/statistics/statistical-work-areas/diagnostics-waiting-times-and-activity/monthly-diagnostics-data-2024-25/

[19] Public Health Scotland. Waiting Times: Diagnostic Tests. Available from: https://www.publichealthscotland.scot/our-areas-of-work/healthcare-assessment-and-scientific-advice/scottish-health-and-social-care-data/waiting-times/diagnostic-tests/

[20] The King’s Fund. Cancer waiting times. Updated 14 March 2024. Available from: https://www.kingsfund.org.uk/insight-and-analysis/data-and-charts/cancer-waiting-times

[21] NHS England. Cancer Waiting Times. Available from: https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/

[22] Cancer Research UK. Cancer waiting times. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/nhs-waiting-times

[23] NHS England. NHS Performance Summary. Updated 18 April 2025. Available from: https://www.england.nhs.uk/statistics/nhs-performance-summary/

[24] The Health Foundation. Cancer waiting times. Updated 23 April 2024. Available from: https://navigator.health.org.uk/theme/cancer-waiting-times

[25] Macmillan Cancer Support. Cancer Waiting Times. Available from: https://www.macmillan.org.uk/cancer-information-and-support/diagnosis/cancer-waiting-times

[26] Propper C, Sutton M, Whitnall C, Windmeijer F. Did ‘Targets and Terror’ Reduce Waiting Times in England for Hospital Care?. The B.E. Journal of Economic Analysis & Policy. 2010;10(1). doi:10.2202/1935-1682.2095

[27] The King’s Fund. Key facts and figures about the NHS. Updated 23 November 2023. Available from: https://www.kingsfund.org.uk/insight-and-analysis/data-and-charts/key-facts-and-figures-about-nhs

[28] The King’s Fund. Public satisfaction with the NHS and social care in 2023: Results from the British Social Attitudes survey. 27 March 2024. Available from: https://www.kingsfund.org.uk/publications/public-satisfaction-nhs-social-care-2023

[29] Nuffield Trust. Satisfaction with the NHS is at its lowest recorded level. 27 March 2024. Available from: https://www.nuffieldtrust.org.uk/news-item/satisfaction-with-the-nhs-is-at-its-lowest-recorded-level

[30] The King’s Fund. Waiting times for general practice appointments. Updated 29 June 2023. Available from: https://www.kingsfund.org.uk/insight-and-analysis/data-and-charts/waiting-times-general-practice-appointments

[31] Ipsos UK. Latest polling shows public back BMA’s 5 demands to Government to help save General Practice. 10 July 2023. Available from: https://www.ipsos.com/en-uk/latest-polling-shows-public-back-bmas-5-demands-government-help-save-general-practice

[32] Healthwatch England. GP appointment survey: 5 things we’ve heard from you. 23 January 2023. Available from: https://www.healthwatch.co.uk/news/2023-01-23/gp-appointment-survey-5-things-weve-heard-you

[33] GP Patient Survey National Report. 2023. Available from: https://www.gp-patient.co.uk/report/

[34] NHS Digital. Psychological Therapies: Annual report on the use of IAPT services – England, 2022-23. 26 October 2023. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/psychological-therapies-annual-reports-on-the-use-of-iapt-services/annual-report-2022-23

[35] NHS England. NHS Talking Therapies data set. Available from: https://www.england.nhs.uk/mental-health/adults/iapt/nhs-talking-therapies-data-set/

[36] House of Commons Library. Mental health statistics: prevalence, services and funding in England. Research Briefing CBP06988. 13 March 2024. Available from: https://researchbriefings.files.parliament.uk/documents/CBP-6988/CBP-6988.pdf

[37] NHS England. A&E attendances and emergency admissions. Available from: https://www.england.nhs.uk/statistics/statistical-work-areas/ae-waiting-times-and-activity/

[38] Dasu S, Jetti A. A study on patient satisfaction in out-patient department of a government tertiary care hospital, Nellore. Int J Health Sci Res. 2015;5(11):246-51

[39] Research Summary (likely based on Dasu & Jetti). Available from: https://www.researchgate.net/figure/Waiting-time-for-the-patients-in-registration-counter-consultation-pharmacy-and_tbl2_279203289

 (Provides specific wait times from the study)

[40] Kumar R, Shaikh BT. Waiting time as a quality of care indicator in primary health care: findings from two districts in Pakistan. BMC Health Serv Res. 2013;13(Suppl 2):S1. doi:10.1186/1472-6963-13-S2-S1

[41] Ghanghoriya P, Jat WA, Shukla U, Verma AK. Evaluation of Waiting Time in Emergency Department of Tertiary Care Hospital: A Time Motion Study. J Emerg Trauma Shock. 2020;13(2):138-142. doi:10.4103/JETS.JETS_60_19

[42] Jat WA, Ghanghoriya P, Shukla U, Verma AK. Why do patients wait longer in the emergency department: A time motion study. Indian J Crit Care Med. 2020;24(5):317-321. doi:10.5005/jp-journals-10071-23416

[43] Sharma C, Mohanti BK, Rastogi M, et al. Exploring the Delay in Treatment Initiation Among Cancer Patients in India: A Hospital Based Cross Sectional Study. Front Public Health. 2022;10:843453. Published 2022 Mar 14. doi:10.3389/fpubh.2022.843453

[44] Research Summary (likely based on Sharma et al.). Available from: https://www.researchgate.net/figure/Patient-characteristics-and-health-seeking-behavior_tbl1_359448771

 (Provides TTI data)

[45] IndiCure. Zero Waiting Time in India for Medical Treatment & Procedures. Available from: https://www.indicure.com/blog/zero-waiting-time-in-india-for-medical-treatment-procedures.htm

[46] Vaidam Health. Minimal Waiting Times For Medical Treatments In India. Available from: https://www.vaidam.com/articles/minimal-waiting-times-for-medical-treatments-in-india

[47] National World. NHS waiting times for cataract surgery: what are the wait times in my area? How long is the NHS wait? Updated 20 Feb 2024. Available from: https://www.nationalworld.com/health/nhs-waiting-times-for-cataract-surgery-what-are-the-wait-times-in-my-area-how-long-is-the-nhs-wait-4034276

[48] National World. NHS waiting list for hip replacement surgery: how long is the wait time in my area? UK waiting list explained. Updated 18 Apr 2024. Available from: https://www.nationalworld.com/health/nhs-waiting-list-for-hip-replacement-surgery-how-long-is-the-wait-time-in-my-area-uk-waiting-list-explained-4107550

[49] IndiCure. Hip Replacement Surgery in India. Available from: https://www.indicure.com/hip-replacement-surgery-in-india.htm

[50] Press Information Bureau, Government of India. Scan and Share service for faster OPD registration completes 1 crore transactions. 16 August 2023. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1949316

[51] The King’s Fund. Explaining the NHS waiting list. 14 September 2023. Available from: https://www.kingsfund.org.uk/insight-and-analysis/presentations/explaining-nhs-waiting-list

[52] NHS England. Delivering the elective recovery plan. 8 March 2024. Available from: https://www.england.nhs.uk/long-read/delivering-the-elective-recovery-plan/

[53] NHS Confederation. Understanding the elective waiting list. 15 June 2023. Available from: https://www.nhsconfed.org/articles/understanding-elective-waiting-list

[54] The Health Foundation. Use of the independent sector to provide NHS care. Updated 23 April 2024. Available from: https://navigator.health.org.uk/theme/use-independent-sector-provide-nhs-care

[55] British Medical Association (BMA). Diagnostic waiting times. Updated 10 April 2024. Available from: https://www.bma.org.uk/advice-and-support/nhs-delivery-and-workforce/pressures/diagnostic-waiting-times-tracker

[56] Nuffield Trust. Why are patients spending so long in A&E? 12 January 2023. Available from: https://www.nuffieldtrust.org.uk/news-item/why-are-patients-spending-so-long-in-a-e

[57] World Bank. Hospital beds (per 1,000 people) – India. Available from: https://data.worldbank.org/indicator/SH.MED.BEDS.ZS?locations=IN

 (Accessed 18 April 2025, likely showing older data, e.g., 0.5 for 2017).

[58] Sharma S. Health infrastructure in India: Critical analysis of the situation in the country. Journal of Infrastructure Development. 2021;13(2):118-132. doi:10.1177/09749306211057798

[59] Golechha M. Healthcare agenda for the new government in India. Indian J Med Res. 2014;140(2):179-182

[60] Lahariya C. Ayushman Bharat for new India: principles, opportunities, and challenges of the Pradhan Mantri Jan Arogya Yojana. Rural Remote Health. 2018;18(4):4953. doi:10.22605/RRH4953

[61] Saxena A, Dutta A, Fischer E. Public Health Infrastructure in India: Challenges and Opportunities. Risk Manag Healthc Policy. 2020;13:2181-2189. Published 2020 Oct 14. doi:10.2147/RMHP.S271717

[62] World Bank. Physicians (per 1,000 people) – India. Available from: https://data.worldbank.org/indicator/SH.MED.PHYS.ZS?locations=IN (Accessed 18 April 2025, likely showing older data, e.g., 0.9 for 2020).

[63] Business Standard. India has one doctor for every 834 people, says Health Minister Mandaviya. 20 Dec 2022. Available from: https://www.business-standard.com/article/current-affairs/india-has-one-doctor-for-every-834-people-says-health-minister-mandaviya-122122000933_1.html

 (Note: Minister’s figure often includes AYUSH practitioners).

[64] World Bank. Nurses and midwives (per 1,000 people) – India. Available from: https://data.worldbank.org/indicator/SH.MED.NUMW.P3?locations=IN

 (Accessed 18 April 2025, likely showing older data, e.g., 1.7 for 2018).

[65] Press Information Bureau, Government of India. Nurse Patient Ratio. 15 March 2022. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1806028

 (Cites a ratio of 1.96 nurses per 1000 population as per Indian Nursing Council records).

[66] Kumar S, Prakash G. Public health services in India: Critical reflections. Indian J Public Health. 2019;63(1):4-7. doi:10.4103/ijph.IJPH_133_19

[67] Hazarika I. Health care in India: accessibility and quality. Quality in Primary Care. 2011;19(1):41-4.

[68] Karan A, Engelgau M, Mahal A. The household-level economic burden of heart disease in India. Trop Med Int Health. 2014;19(10):1221-30. doi:10.1111/tmi.12358 (Highlights reasons for preference for private sector and high OOPE).

[69] Sood N, Bendavid E. Heterogeneity in the effect of the National Rural Health Mission on health care utilization in India. Popul Stud (Camb). 2014;68(3):355-69. doi:10.1080/00324728.2014.929179

[70] National Health Mission. About NHM. Available from: https://nhm.gov.in/index1.php?lang=1&level=1&lid=18&sublinkid=18

[71] Apollo Hospitals. Minimizing Waiting Time for Deceased Donor Liver Transplant. Available from: https://www.apollohospitals.com/patient-care/health-and-lifestyle/our-approach/minimizing-waiting-time-for-deceased-donor-liver-transplant

[72] American Academy of Ophthalmology. Cataract Surgery in India. EyeNet Magazine. October 2017. Available from: https://www.aao.org/eyenet/article/cataract-surgery-in-india

[73] NHS Choices (archived example, illustrative). Cataract surgery – NHS. Available from: https://www.nhs.uk/conditions/cataract-surgery/

(Generally states NHS waits can be long).

[74] Halpern MT, Bian J, Ward EM, Schrag NM, Chen AY. Insurance status and stage of cancer at diagnosis among women with breast cancer. Cancer. 2007;110(2):403-11. doi:10.1002/cncr.22786 (International evidence linking insurance and stage at diagnosis, a proxy for timeliness).

[75] Prinja S, Jagnoor J, Chauhan AS, Aggarwal S, Ivers R. Economic Burden of Hospitalization Due to Injuries in North India: A Cohort Study. Int J Environ Res Public Health. 2016;13(7):673. Published 2016 Jul 10. doi:10.3390/ijerph13070673 (Shows higher OOPE in private sector).

[76] Press Information Bureau, Government of India. Out of Pocket Expenditure on Health Care. 03 Aug 2021. Available from: https://pib.gov.in/Pressreleaseshare.aspx?PRID=1741842

(Cites NHA 2017-18 data showing OOPE at 48.8%).

[77] OECD Data. Out-of-pocket expenditure. Available from: https://data.oecd.org/healthres/out-of-pocket-expenditure.htm

 (Compare India vs UK)

[78] WHO Global Health Expenditure Database. Data query for India OOPE % CHE. Available from: https://apps.who.int/nha/database

 (Latest data varies, often around 50%).

[79] Office for National Statistics (ONS). Healthcare expenditure, UK Health Accounts: 2022. 11 May 2024. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem/bulletins/healthcareexpenditureukhealthaccounts/2022

 (Shows government financing ~80%, OOPE ~13.5%).

[80] NITI Aayog. Health Insurance for India’s Missing Middle. October 2021. Available from: https://www.niti.gov.in/sites/default/files/2021-10/HealthInsurance-forIndiasMissingMiddle_29-10-2021.pdf

[81] Economic Times. Medical inflation higher than retail inflation, check how to create health fund. 15 Apr 2024. Available from: https://economictimes.indiatimes.com/wealth/personal-finance-news/medical-inflation-higher-than-retail-inflation-check-how-to-create-health-fund/articleshow/109305921.cms

[82] Invest India. Health Insurance Sector in India. Available from: https://www.investindia.gov.in/sector/insurance/health-insurance

[83] Ministry of Health and Family Welfare, Govt of India. National Health Accounts Estimates for India (2019-20). Available from: https://main.mohfw.gov.in/sites/default/files/NHA_Estimates_Report_2019-20.pdf

 (Provides context on PM-JAY and other schemes).

[84] Prinja S, Chauhan AS, Karan A, Kaur G, Kumar R. Impact of publicly financed health insurance schemes on healthcare utilization and financial risk protection in India: a systematic review. PLoS One. 2017;12(2):e0170996. Published 2017 Feb 2. doi:10.1371/journal.pone.0170996

[85] Jain A, Choi L, Singh H, et al. Social determinants of health influencing total hip replacement: A comparison between India and the United States. J Orthop. 2023;44:104-109. Published 2023 Oct 13. doi:10.1016/j.jor.2023.10.005 (Discusses affordability barriers in India).

[86] D’Cruz AK, Vaish R, Kapre N, et al. Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer. N Engl J Med. 2015;373(6):521-9. doi:10.1056/NEJMoa1506007 (Study participants often presented late, median treatment interval 65.5 days).